ATE427116T1 - Behandlung von bakteriellen infektionen - Google Patents

Behandlung von bakteriellen infektionen

Info

Publication number
ATE427116T1
ATE427116T1 AT05717847T AT05717847T ATE427116T1 AT E427116 T1 ATE427116 T1 AT E427116T1 AT 05717847 T AT05717847 T AT 05717847T AT 05717847 T AT05717847 T AT 05717847T AT E427116 T1 ATE427116 T1 AT E427116T1
Authority
AT
Austria
Prior art keywords
polypeptides
treatment
bacterial infections
objects
nucleic acids
Prior art date
Application number
AT05717847T
Other languages
English (en)
Inventor
Curtis Dobson
Keith Crutcher
Original Assignee
Ai2 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ai2 Ltd filed Critical Ai2 Ltd
Application granted granted Critical
Publication of ATE427116T1 publication Critical patent/ATE427116T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Materials For Medical Uses (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Eyeglasses (AREA)
AT05717847T 2004-02-27 2005-02-28 Behandlung von bakteriellen infektionen ATE427116T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0404374.1A GB0404374D0 (en) 2004-02-27 2004-02-27 Treatment of bacterial infections

Publications (1)

Publication Number Publication Date
ATE427116T1 true ATE427116T1 (de) 2009-04-15

Family

ID=32050981

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05717847T ATE427116T1 (de) 2004-02-27 2005-02-28 Behandlung von bakteriellen infektionen

Country Status (11)

Country Link
US (1) US8524861B2 (de)
EP (1) EP1718325B1 (de)
JP (2) JP5270150B2 (de)
CN (1) CN1925866B (de)
AT (1) ATE427116T1 (de)
AU (1) AU2005216703B2 (de)
CA (1) CA2554486C (de)
DE (1) DE602005013648D1 (de)
ES (1) ES2324481T3 (de)
GB (1) GB0404374D0 (de)
WO (1) WO2005082399A2 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9216106B2 (en) 2003-04-09 2015-12-22 Directcontact Llc Device and method for the delivery of drugs for the treatment of posterior segment disease
GB0329958D0 (en) * 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
EP1843776A4 (de) * 2004-07-06 2011-05-11 3D Matrix Inc Gereinigte amphile peptid-zusammensetzungen und ihre verwendung
GB0513096D0 (en) * 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections
CN101611152B (zh) 2006-12-21 2013-10-16 克格诺西有限公司 用于调控set的方法及其用途
GB0818074D0 (en) * 2008-10-02 2008-11-05 Lytix Biopharma As Treatment of biofilms
ES2694000T3 (es) 2008-10-06 2018-12-17 3-D Matrix Ltd. Tapón de tejido
FR2937322B1 (fr) * 2008-10-22 2013-02-22 Vect Horus Derives peptidiques et leur utilisation comme vecteurs de molecules sous forme de conjugues
US20110046747A1 (en) * 2009-02-19 2011-02-24 Kelvin Wai Kwok Yeung Antibacterial surface and method of fabrication
JP2012180302A (ja) * 2011-03-01 2012-09-20 Tokai Univ 抗グラム陰性菌剤
US9234026B2 (en) * 2011-07-21 2016-01-12 University of Pittsburgh—of the Commonwealth System of Higher Education Apolipoprotein E polypeptides and their use
US8979260B1 (en) * 2011-10-18 2015-03-17 Indicator Systems International, Inc. Contact lenses with indicators
ES2706065T3 (es) 2012-07-06 2019-03-27 3 D Matrix Ltd Proceso de llenado-acabado para soluciones de péptidos
KR101553685B1 (ko) * 2014-01-28 2015-09-17 주식회사 인터로조 항균성의 하이드로겔 콘택트렌즈 및 그 제조방법
GB201401877D0 (en) * 2014-02-04 2014-03-19 Univ Tromsoe Peptides
ES2712608T3 (es) 2014-03-10 2019-05-14 3 D Matrix Ltd Péptidos autoensamblantes para el tratamiento de las bullas pulmonares
JP6684719B2 (ja) 2014-03-10 2020-04-22 株式会社スリー・ディー・マトリックス ペプチド組成物の滅菌および濾過
BR112016020584A2 (pt) 2014-03-10 2017-10-03 3 D Matrix Ltd Composições de peptídeo auto-organizável
CN104974228B (zh) * 2015-06-15 2017-10-17 四川合泰新光生物科技有限公司 一种小分子多肽zy4及其应用
US10814038B2 (en) 2016-01-06 2020-10-27 3-D Matrix, Ltd. Combination compositions
EP3723726A1 (de) 2017-12-15 2020-10-21 3-D Matrix, Ltd. Tensidpeptidnanostrukturen und verwendungen in der wirkstoffabgabe
CN112480230B (zh) * 2020-11-30 2022-05-03 青岛农业大学 一种具有更好抗热功能的抗菌肽及其应用

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294605A (en) 1990-07-19 1994-03-15 The Scripps Research Institute Amphiphilic peptide compositions and analogues thereof
US5344822A (en) 1992-08-12 1994-09-06 The Rogosin Institute Methods useful in endotoxin prophylaxis and therapy
FR2697022B1 (fr) * 1992-10-19 1994-12-16 Pasteur Institut Antigènes de Plasmodium falciparum capables d'induire des anticorps protecteurs à large spectre - Application à la vaccination.
WO1997017990A1 (en) * 1995-11-14 1997-05-22 Xoma Corporation Bactericidal permeability increasing protein (bpi) for treating conditions associated with corneal injury
GB9705831D0 (en) 1997-03-20 1997-05-07 Univ Leicester Oxidised ldl
KR100314721B1 (ko) 1998-01-22 2001-11-23 김일웅 생물학적 활성이 있는 신규한 펩타이드
US7205280B2 (en) * 1998-03-11 2007-04-17 Cognosci, Inc. Methods of suppressing microglial activation
WO1999045950A2 (en) 1998-03-11 1999-09-16 Duke University Methods of suppressing microglial activation
WO2000066145A1 (en) * 1999-04-30 2000-11-09 Keio University Method for inducing the cell death of nerve cell line, method for screening compound inhibiting or promoting the cell death of nerve cells, and cell death inhibitor and promoter for nerve cells
US6664230B1 (en) 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
GB0103424D0 (en) * 2001-02-12 2001-03-28 Chiron Spa Gonococcus proteins
US20040014955A1 (en) 2001-12-17 2004-01-22 Carlos Zamudio Identification of essential genes of cryptococcus neoformans and methods of use
CN1269837C (zh) * 2002-09-02 2006-08-16 上海高科联合生物技术研发有限公司 一组合成抗菌肽
US20050208078A1 (en) * 2003-11-20 2005-09-22 Hoffman Stephen L Methods for the prevention of malaria
CA2541117A1 (en) 2003-10-01 2005-05-06 Children's Hospital & Research Center At Oakland Lipophilic drug delivery vehicle and methods of use thereof
AU2004291503A1 (en) * 2003-11-13 2005-06-02 Janssen Pharmaceutica N.V. Immobilized N-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets
GB0329254D0 (en) 2003-12-17 2004-01-21 Univ Manchester Treatment of viral infections
GB0329958D0 (en) 2003-12-24 2004-01-28 Univ Manchester Treatment of viral infections
GB0404374D0 (en) * 2004-02-27 2004-03-31 Univ Manchester Treatment of bacterial infections
GB0513096D0 (en) 2005-06-28 2005-08-03 Strathclyde Treatment of microbial infections

Also Published As

Publication number Publication date
DE602005013648D1 (de) 2009-05-14
JP2007524420A (ja) 2007-08-30
JP2013051965A (ja) 2013-03-21
US8524861B2 (en) 2013-09-03
CN1925866B (zh) 2012-09-05
CA2554486C (en) 2013-09-17
ES2324481T3 (es) 2009-08-07
WO2005082399A2 (en) 2005-09-09
WO2005082399A3 (en) 2005-12-22
US20090169598A1 (en) 2009-07-02
AU2005216703B2 (en) 2011-06-23
AU2005216703A1 (en) 2005-09-09
CN1925866A (zh) 2007-03-07
JP5270150B2 (ja) 2013-08-21
AU2005216703A2 (en) 2005-09-09
EP1718325B1 (de) 2009-04-01
CA2554486A1 (en) 2005-09-09
EP1718325A2 (de) 2006-11-08
GB0404374D0 (en) 2004-03-31

Similar Documents

Publication Publication Date Title
ATE427116T1 (de) Behandlung von bakteriellen infektionen
CY1110177T1 (el) Ω-καρβοξυαρυλο υποκατεστημενες διφαινυλουριες ως αναστολεις της raf κινασης
DK1377314T3 (da) Monoklonale antistoffer mod CLFA-proteinet og fremgangsmåder til anvendelse i behandling eller forebyggelse af infektioner
CY1111225T1 (el) Νεα πεπτιδια ως αναστολεις πρωτεασης νs3-σερινης ιου ηπατiτιδας c
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
DE60330161D1 (de) Rifalazil zur behandlung von infektionen mit clostridium difficile
ATE310089T1 (de) Von dem syndrom der weissen flecken virus abgeleitete proteine und deren verwendungen
ATE354585T1 (de) Antibakterielle amid-makrozyklen
ATE486634T1 (de) Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza
MX2017016227A (es) Peptidos anti-infecciosos de amplio espectro.
WO2004098536A3 (en) Anti-viral activity of cathelicidin peptides
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
DE602004025689D1 (de) Antivirale mittel zur behandlung, kontrolle und prävention von infektionen durch coronaviren
MX394323B (es) Uso de una composición antibacteriana para tratar infecciones por estafilococos.
ATE452138T1 (de) Antibakterielle peptide und analoga davon
DE60312684D1 (de) Plazenta-wachstumsfaktor als target für die behandlung von osteoporose
BRPI0411168A (pt) composição para o tratamento dos cabelos, usos de uma composição e método de tratamento dos cabelos
BRPI0410967A (pt) compostos, composições e seus usos para o tratamento de infecções por vìrus da famìlia flaviviridae
ATE495186T1 (de) Antibakterielle amid-makrozyklen iv
ATE361354T1 (de) Korrosionsschutzmittel zur oberflächlichen behandlung von gläsernem spülgut
HUP0401586A2 (hu) Baktériumellenes szer
WO2005080549A3 (de) Trioxacarcine und deren verwendung gegen infektionskrankheiten
EP1482958A4 (de) Verfahren zur behandlung, prävention oder hemmung von enterotoxigenen infektionen mit escherichia coli mit rindererythrozyten-präparaten
ATE544453T1 (de) Kombinationstherapien mit l-fmau zur behandlung von hepatitis-b-virus-infektionen
DE602004012759D1 (de) Behandlung von fibrosen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties